BioNTech SE(BNTX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BNTX BioNTech SE

已收盘 11-21 16:00:00 EST

108.23

+6.09

+5.96%

盘后108.75

+0.52+0.48%

19:37 EST

最高108.74	最低101.26	成交量103.34万
今开102.38	昨收102.14	日振幅7.32%
总市值259.47亿	流通市值100.78亿	总股本2.40亿
成交额1.10亿	换手率1.11%	流通股本9,312万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"BNTX","market":"US","secType":"STK","nameCN":"BioNTech SE","latestPrice":108.23,"timestamp":1732222800000,"preClose":102.14,"halted":0,"volume":1033381,"hourTrading":{"tag":"盘后","latestPrice":108.75,"preClose":108.23,"latestTime":"19:37 EST","volume":6486,"amount":701837.89,"timestamp":1732235866075},"delay":0,"floatShares":93120385,"shares":239739752,"eps":-2.164897,"marketStatus":"已收盘","marketStatusCode":5,"change":6.09,"latestTime":"11-21 16:00:00 EST","open":102.38,"high":108.74,"low":101.26,"amount":109738279.087116,"amplitude":0.073233,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.164897,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1732266000000},"adr":0,"listingDate":1570680000000,"adjPreClose":102.14,"adrRate":1,"preHourTrading":{"tag":"盘前","latestPrice":102.42,"preClose":102.14,"latestTime":"09:21 EST","volume":3111,"amount":317401.51716,"timestamp":1732198899251},"postHourTrading":{"tag":"盘后","latestPrice":108.75,"preClose":108.23,"latestTime":"19:37 EST","volume":6486,"amount":701837.89,"timestamp":1732235866075},"volumeRatio":0.595651,"impliedVol":0.4311,"impliedVolPercentile":0.8056},"requestUrl":"/m/hq/s/BNTX","defaultTab":"news","newsList":[{"id":"2485444151","title":"Biontech Se盘中异动 下午盘股价大涨5.02%报107.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485444151","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485444151?lang=zh_cn&edition=full","pubTime":"2024-11-22 03:34","pubTimestamp":1732217657,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日03时34分，Biontech Se股票出现波动，股价急速拉升5.02%。截至发稿，该股报107.27美元/股，成交量54.8894万股，换手率0.23%，振幅5.85%。Biontech Se股票所在的生物技术行业中，整体涨幅为0.39%。Biontech Se公司简介：BioNTech 是一家总部位于德国的生物技术公司，专注于开发癌症疗法，包括个体化免疫疗法，以及包括新冠病毒在内的传染病疫苗。BioNTech 与多家大型制药公司合作，包括罗氏、礼来、辉瑞、赛诺菲和 Genmab。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122033417abd56333&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122033417abd56333&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4585","BK4588","BK4548","BK4551","BNTX","BK4568","BK4535"],"gpt_icon":0},{"id":"2485122283","title":"Biontech Se盘中异动 下午盘快速下跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485122283","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485122283?lang=zh_cn&edition=full","pubTime":"2024-11-21 03:44","pubTimestamp":1732131896,"startTime":"0","endTime":"0","summary":"北京时间2024年11月21日03时44分，Biontech Se股票出现波动，股价快速跳水5.00%。截至发稿，该股报101.08美元/股，成交量70.8274万股，换手率0.30%，振幅4.51%。Biontech Se股票所在的生物技术行业中，整体涨幅为0.30%。Biontech Se公司简介：BioNTech 是一家总部位于德国的生物技术公司，专注于开发癌症疗法，包括个体化免疫疗法，以及包括新冠病毒在内的传染病疫苗。BioNTech 与多家大型制药公司合作，包括罗氏、礼来、辉瑞、赛诺菲和 Genmab。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121034457abd2b67d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121034457abd2b67d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BNTX","BK4551","BK4585","BK4568","BK4535","BK4139","BK4548"],"gpt_icon":0},{"id":"1152930695","title":"异动解读 | 辉瑞合作伙伴BioNTech 股价盘中大涨5.21%,可能与公司前景良好有关","url":"https://stock-news.laohu8.com/highlight/detail?id=1152930695","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1152930695?lang=zh_cn&edition=full","pubTime":"2024-11-19 23:46","pubTimestamp":1732031197,"startTime":"0","endTime":"0","summary":"德国生物技术公司 BioNTech SE 今日盘中股价出现大涨,上涨5.21%。\n\n作为开发新冠疫苗\"科兴疫苗\"并与辉瑞公司达成合作的公司,BioNTech公司在癌症和传染病疫苗方面拥有很强的研发实力。除了继续开发针对新冠的疫苗和药物外,BioNTech 还在推进包括个体化免疫疗法在内的癌症治疗研究。\n\n公司前景看好可能是导致股价上涨的重要原因。分析人士认为,BioNTech 的产品线储备充足,与多家知名制药企业建立了合作关系,未来有望持续取得良好的业绩表现。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | 辉瑞合作伙伴BioNTech 股价盘中大涨5.21%,可能与公司前景良好有关","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["BNTX"],"gpt_icon":0},{"id":"2484929453","title":"Biontech Se盘中异动 股价大涨5.12%报107.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484929453","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484929453?lang=zh_cn&edition=full","pubTime":"2024-11-19 23:42","pubTimestamp":1732030972,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日23时42分，Biontech Se股票出现波动，股价大幅上涨5.12%。截至发稿，该股报107.09美元/股，成交量36.1008万股，换手率0.15%，振幅4.05%。Biontech Se股票所在的生物技术行业中，整体跌幅为1.04%。Biontech Se公司简介：BioNTech 是一家总部位于德国的生物技术公司，专注于开发癌症疗法，包括个体化免疫疗法，以及包括新冠病毒在内的传染病疫苗。BioNTech 与多家大型制药公司合作，包括罗氏、礼来、辉瑞、赛诺菲和 Genmab。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119234252971a778c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119234252971a778c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BNTX","BK4535","BK4548","BK4588","BK4139","BK4551","BK4568","BK4585"],"gpt_icon":0},{"id":"2484676518","title":"Biontech Se涨0.59% 股价突破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2484676518","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484676518?lang=zh_cn&edition=full","pubTime":"2024-11-18 22:37","pubTimestamp":1731940644,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日22时37分，Biontech Se股票出现波动，股价大幅拉升0.59%。截至发稿，该股报100.31美元/股，成交量5.6939万股，换手率0.02%，振幅0.98%。Biontech Se股票所在的生物技术行业中，整体涨幅为0.03%。Biontech Se公司简介：BioNTech 是一家总部位于德国的生物技术公司，专注于开发癌症疗法，包括个体化免疫疗法，以及包括新冠病毒在内的传染病疫苗。BioNTech 与多家大型制药公司合作，包括罗氏、礼来、辉瑞、赛诺菲和 Genmab。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822372598e433fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822372598e433fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4535","BK4588","BK4585","BK4139","BK4548","BNTX","BK4568","BK4551"],"gpt_icon":0},{"id":"2483882105","title":"“史上最有杀伤力”美国卫生部长提名！疫苗股连日崩跌，肯尼迪被斥危害公众健康第一人","url":"https://stock-news.laohu8.com/highlight/detail?id=2483882105","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483882105?lang=zh_cn&edition=full","pubTime":"2024-11-16 07:08","pubTimestamp":1731712131,"startTime":"0","endTime":"0","summary":"周五BioNTech一度跌近9%，Moderna跌超8%。行业媒体人士称，肯尼迪的“垃圾科学”对公众健康威胁巨大。华尔街分析师认为，反疫苗斗士肯尼迪得到提名让生物技术行业面临巨大不确定性，可能对行业产生深远且难以预测的影响。","market":"us","thumbnail":"https://static.tigerbbs.com/f47a446752e5215a6ecce2f88bd9de33","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/f47a446752e5215a6ecce2f88bd9de33"],"rights":{"source":"wallstreetcn_hot_news","url":"https://wallstreetcn.com/articles/3734272","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3734272","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"“史上最有杀伤力”美国卫生部长提名！疫苗股连日崩跌，肯尼迪被斥危害公众健康第一人","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"wallstreetcn_hot_news","symbols":["MRNA","BNTX","PFE"],"gpt_icon":1},{"id":"2483932306","title":"BUZZ--美国股票走势-OneStream、FuelCell Energy、阿里巴巴","url":"https://stock-news.laohu8.com/highlight/detail?id=2483932306","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483932306?lang=zh_cn&edition=full","pubTime":"2024-11-16 00:01","pubTimestamp":1731686480,"startTime":"0","endTime":"0","summary":".N美国东部时间10:30，道琼斯工业平均指数.DJI下跌0.65%，报43,468.44点；标普500指数.SPX下跌1.13%，报5,881.73点；纳斯达克综合指数.IXIC下跌1.86%，报18,753.02点。标准普尔 500 指数.PG.INX百分比涨幅前三名是： ** Palantir Technologies Inc PLTR.N，上涨 6.3. ** Charles River Laboratories International Inc CRL.N，下跌 6.0","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241115:nL4S3MM19X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BABA","ULTA","COIN","GTN","NVAX","CMA","MARA","QUBT","ALUR","AGCO","NKE","PLTR","CERO","EYEN","HBBD.SI","POOL","DESP","OKLO","RIOT","AKYA","ATAI","DE","PHR","FCEL","DPZ","CRL","TFFP","CMPS","09988","BAC","OS","AMAT","CNH","DIS","KGS","89988","ARE","PFE","BNTX","FITB","HUT","CF","SPPL","LU0149721374.USD","GHRS","LU2462157665.USD","DKNG","MRNA","IE00BJTD4N35.SGD","BE"],"gpt_icon":1},{"id":"2483372293","title":"Biontech Se跌3.54% 股价跌破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2483372293","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483372293?lang=zh_cn&edition=full","pubTime":"2024-11-15 22:30","pubTimestamp":1731681045,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日22时30分，Biontech Se股票出现异动，股价急速下挫3.54%。截至发稿，该股报99.89美元/股，成交量14.8177万股，换手率0.06%，振幅0.14%。Biontech Se股票所在的生物技术行业中，整体涨幅为0.00%。Biontech Se公司简介：BioNTech 是一家总部位于德国的生物技术公司，专注于开发癌症疗法，包括个体化免疫疗法，以及包括新冠病毒在内的传染病疫苗。BioNTech 与多家大型制药公司合作，包括罗氏、礼来、辉瑞、赛诺菲和 Genmab。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111522304598e42ea8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111522304598e42ea8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4551","BK4548","BK4139","BK4568","BK4535","BNTX","BK4585"],"gpt_icon":0},{"id":"2483597453","title":"BUZZ-特朗普任命肯尼迪为卫生机构负责人，疫苗制造商和包装食品公司业绩下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2483597453","media":"路透中文","labels":["Policy And Regulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483597453?lang=zh_cn&edition=full","pubTime":"2024-11-15 06:41","pubTimestamp":1731624112,"startTime":"0","endTime":"0","summary":"11月14日 - ** 由于美国当选总统特朗普选择小罗伯特-肯尼迪领导卫生与公众服务部，疫苗生产商的股票在周四交易时段结束时暴跌。(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"8b50228a679c44f870e44bbf889089f6","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241114:nL4T3ML222:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Policy And Regulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4534","LU1934455277.USD","LU0109981661.USD","LU1066051225.USD","LU0575583348.USD","IE00BJT1NW94.SGD","GSK.UK","LU1057294990.SGD","LU1645745479.HKD","LU1015430645.USD","IE00B19Z3581.USD","LU0006061336.USD","LU1941712264.USD","KHC","LU0265550946.USD","SNY","BK4007","LU1066053197.SGD","LU2361044865.SGD","IE00B1BXHZ80.USD","IE00B4R5TH58.HKD","SG9999014559.SGD","PEP","IE00B19Z3B42.SGD","LU1037948541.HKD","LU0985481810.HKD","BNTX","LU1929549753.HKD","IE00BWDBJ516.SGD","LU1989772923.USD","SG9999011175.SGD","MRNA","LU0965509101.SGD","LU1098665638.USD","SGXZ57979304.SGD","IE00BFTCPJ56.SGD","LU0006306889.USD","LU0965508806.USD","LU1917777945.USD","SYY","LU1035777561.USD","LU0868494617.USD","IE0002270589.USD","LU1481599808.USD","PFE","MRK","LU0971552673.USD","LU1989772840.SGD","LU1699723380.USD"],"gpt_icon":1},{"id":"2483346793","title":"Biontech Se盘中异动 股价大跌5.38%报105.48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483346793","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483346793?lang=zh_cn&edition=full","pubTime":"2024-11-15 04:40","pubTimestamp":1731616806,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日04时40分，Biontech Se股票出现波动，股价快速跳水5.38%。截至发稿，该股报105.48美元/股，成交量78.8351万股，换手率0.33%，振幅8.90%。Biontech Se股票所在的生物技术行业中，整体跌幅为1.81%。Biontech Se公司简介：BioNTech 是一家总部位于德国的生物技术公司，专注于开发癌症疗法，包括个体化免疫疗法，以及包括新冠病毒在内的传染病疫苗。BioNTech 与多家大型制药公司合作，包括罗氏、礼来、辉瑞、赛诺菲和 Genmab。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111504400698e42ba4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111504400698e42ba4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4548","BK4568","BK4551","BK4588","BK4139","BK4585","BNTX","BK4535"],"gpt_icon":0},{"id":"2483882981","title":"Biontech Se盘中异动 早盘股价大涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483882981","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483882981?lang=zh_cn&edition=full","pubTime":"2024-11-13 22:59","pubTimestamp":1731509945,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日22时59分，Biontech Se股票出现异动，股价急速上涨5.08%。截至发稿，该股报111.72美元/股，成交量15.7233万股，换手率0.07%，振幅5.14%。Biontech Se股票所在的生物技术行业中，整体涨幅为0.26%。Biontech Se公司简介：BioNTech 是一家总部位于德国的生物技术公司，专注于开发癌症疗法，包括个体化免疫疗法，以及包括新冠病毒在内的传染病疫苗。BioNTech 与多家大型制药公司合作，包括罗氏、礼来、辉瑞、赛诺菲和 Genmab。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113225905971a64ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113225905971a64ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4548","BK4568","BK4551","BK4588","BK4139","BK4585","BNTX","BK4535"],"gpt_icon":0},{"id":"2482427925","title":"Biontech Se2024财年第三财季实现净利润2.18亿美元，同比增加24.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482427925","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482427925?lang=zh_cn&edition=full","pubTime":"2024-11-10 00:02","pubTimestamp":1731168150,"startTime":"0","endTime":"0","summary":"11月10日，Biontech Se公布财报，公告显示公司2024财年第三财季净利润为2.18亿美元，同比增加24.57%；其中营业收入为13.67亿美元，同比增加40.35%，每股基本收益为0.91美元。从资产负债表来看，Biontech Se总负债36.68亿美元，其中短期债务41.74百万美元，资产负债比为6.82，流动比率为7.33。机构评级：截至2024年11月10日，当前有16家机构对Biontech Se目标价做出预测，其中目标均价为137.90美元，其中最低目标价为108.72美元，最高目标价为169.01美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241110000312a2278689&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241110000312a2278689&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BNTX"],"gpt_icon":0},{"id":"2481101661","title":"Biontech Se盘中异动 股价大涨5.88%报114.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481101661","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481101661?lang=zh_cn&edition=full","pubTime":"2024-11-08 22:31","pubTimestamp":1731076270,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日22时31分，Biontech Se股票出现波动，股价快速上涨5.88%。截至发稿，该股报114.22美元/股，成交量7.2084万股，换手率0.03%，振幅0.14%。Biontech Se股票所在的生物技术行业中，整体涨幅为0.56%。Biontech Se公司简介：BioNTech 是一家总部位于德国的生物技术公司，专注于开发癌症疗法，包括个体化免疫疗法，以及包括新冠病毒在内的传染病疫苗。BioNTech 与多家大型制药公司合作，包括罗氏、礼来、辉瑞、赛诺菲和 Genmab。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108223110971a55ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108223110971a55ae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4551","BK4568","BK4535","BNTX","BK4585","BK4139","BK4548"],"gpt_icon":0},{"id":"1115700719","title":"异动解读 | BioNTech股价大跌逾5% 新冠疫苗销量下滑或是主因","url":"https://stock-news.laohu8.com/highlight/detail?id=1115700719","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1115700719?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:57","pubTimestamp":1730905063,"startTime":"0","endTime":"0","summary":"德国生物科技公司BioNTech11月6日盘中股价大跌5.19%,报收105.32美元,成为市场关注焦点。BioNTech联手辉瑞研发的Comirnaty新冠疫苗是两家公司共同的重磅产品。随着新冠疫情形势趋缓,全球疫苗需求逐步降温,这种外部环境变化可能直接导致BioNTech的疫苗收入大幅减少。此外,BioNTech也在布局多个前景广阔的抗癌药物和疫苗管线,持续高额研发投入或许也为公司业绩带来一定压力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["BNTX"],"gpt_icon":0},{"id":"2481839479","title":"Biontech Se盘中异动 大幅下跌5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481839479","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481839479?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:45","pubTimestamp":1730904321,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日22时45分，Biontech Se股票出现波动，股价急速下挫5.09%。Biontech Se股票所在的生物技术行业中，整体跌幅为0.42%。Biontech Se公司简介：BioNTech 是一家总部位于德国的生物技术公司，专注于开发癌症疗法，包括个体化免疫疗法，以及包括新冠病毒在内的传染病疫苗。BioNTech 与多家大型制药公司合作，包括罗氏、礼来、辉瑞、赛诺菲和 Genmab。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106224521a21d31f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106224521a21d31f6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4548","BK4535","BK4585","BK4588","BK4551","BK4139","BNTX","BK4568"],"gpt_icon":0},{"id":"1159599990","title":"BioNTech第三季度收入12.4亿欧元，超市场预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1159599990","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1159599990?lang=zh_cn&edition=full","pubTime":"2024-11-04 19:52","pubTimestamp":1730721175,"startTime":"0","endTime":"0","summary":"11月4日，$BioNTech(BNTX)$第三季度收入12.4亿欧元，预期为4.452亿欧元；每股收益0.81欧元，去年同期为0.66欧元，预期亏损1.84欧元。第三季度营业收入1,050万欧元，同比下降86%，预期损失5,775万欧元。第三季度研发费用5.503亿欧元，同比增长11%，预期为6.39亿欧元。财报发布后，BioNTech美股盘前一度上涨4%。","market":"us","thumbnail":"https://static.tigerbbs.com/5ce7e4c84e3c54b81fbaee9cb1c77ad9","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5ce7e4c84e3c54b81fbaee9cb1c77ad9"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":"BioNTech第三季度收入12.4亿欧元，超市场预期","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BNTX"],"gpt_icon":0},{"id":"2480389309","title":"由于 COVID-19 的季节性和库存减记，BioNTech 下调了全年收入展望","url":"https://stock-news.laohu8.com/highlight/detail?id=2480389309","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480389309?lang=zh_cn&edition=full","pubTime":"2024-11-04 19:45","pubTimestamp":1730720705,"startTime":"0","endTime":"0","summary":"    路透11月4日 - 德国制药商BioNTech   周一下调了全年收入指导，理由是COVID-19的吸收和价格水平、库存减记和辉瑞  的费用。BioNTech公司与辉瑞公司合作生产的COVID-19疫苗在流感大流行期间被广泛使用，该公司第三季度的收入为12.4亿欧元，去年同期为8.953亿欧元，这主要得益于其变异适应型COVID-19疫苗较早获得批准。8 月 ，这家总部位于美因茨的公司表示，其研发总支出的约 90% 用于与 COVID 无关的活动，主要是肿瘤学和 mRNA。公司的目标是在 2026 年首次推出肿瘤药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4585","LU1883839398.USD","SG9999001176.USD","SG9999013999.USD","LU0058720904.USD","IE00BLSP4452.SGD","LU0234572021.USD","LU1057294990.SGD","LU0321505439.SGD","LU0321505868.SGD","LU0306806265.USD","SG9999002232.USD","LU1066053197.SGD","LU1023059063.AUD","SGXZ57979304.SGD","LU0225771236.USD","LU0456855351.SGD","BK4581","BK4007","BK4588","LU0225284248.USD","LU1066051498.USD","BK4592","IE00BBT3K403.USD","BK4534","IE0002270589.USD","BK4533","LU0868494617.USD","SG9999003800.SGD","SG9999011175.SGD","BK4550","BK4551","BK4535","LU0289739699.SGD","LU0122379950.USD","BNTX","BK4568","IE00B19Z3B42.SGD","BK4548","LU1894683348.USD","SG9999002224.SGD","IE000M9KFDE8.USD","SG9999001176.SGD","LU1894683264.USD","LU0170899867.USD","IE00B19Z3581.USD","LU0985481810.HKD","LU0306807586.USD"],"gpt_icon":1},{"id":"2472545406","title":"BioNTech(BNTX)盘前跌1% 公司股东拟减持价值近860万美元公司股票","url":"https://stock-news.laohu8.com/highlight/detail?id=2472545406","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472545406?lang=zh_cn&edition=full","pubTime":"2024-10-02 19:00","pubTimestamp":1727866849,"startTime":"0","endTime":"0","summary":"金吾财讯 | BioNTech(BNTX)盘前股价走低，暂跌1%，报118.73美元。根据美国证券交易委员会（SEC）美东时间10月1日披露的文件，公司股东ATHOS KG拟于10月1日出售7.21万股普通股股份，总市值约859.57万美元。ATHOS KG自2024年9月13日起至今合共已减持该公司99.7万股股份，总价值约1.21亿美元。","market":"hk","thumbnail":"https://static.szfiu.com/news/20210810/ZjBiNzEwNDA3MTQ3NjM4OTQ3.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/ZjBiNzEwNDA3MTQ3NjM4OTQ3.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"280479","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BNTX","BK4535","BK4548","BK4588","BK4139","BK4551","BK4568","BK4585"],"gpt_icon":0},{"id":"2472695173","title":"德国将微软列为“对竞争极具重要意义的公司”，加码对其反垄断监管","url":"https://stock-news.laohu8.com/highlight/detail?id=2472695173","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472695173?lang=zh_cn&edition=full","pubTime":"2024-10-01 07:24","pubTimestamp":1727738661,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["IE00BBT3K403.USD","IE00B19Z8X17.USD","IE00B19Z8W00.USD","GB00B4LPDJ14.GBP","IE00B19Z9505.USD","IE00BFSS7M15.SGD","IE00B4JS1V06.HKD","IE00BK4W5M84.HKD","BK4579","IE00B3SWFQ91.USD","BK4527","IE00B7KXQ091.USD","BK4532","IE00BFXG0V08.USD","BK4551","BK4139","IE00BFSS8Q28.SGD","IE00BDCRKT87.USD","IE00B1BXHZ80.USD","BK4577","GB00B4QBRK32.GBP","IE00BDRTCR15.USD","BK4534","IE000KEQY171.SGD","IE00BK4W5L77.USD","BK4548","IE000W1ABFV2.USD","MSFT","BK4576","BK4525","IE00B5TLWC47.USD","BK4585","BK4503","IE0003U64NQ7.SGD","BNTX","BK4528","IE0009356076.USD","IE0004086264.USD","IE0004091025.USD","IE0034235303.USD","BK4588","BK4504","BK4592","BK4587","IE00BKVL7J92.USD","BK4581","IE0005OL40V9.USD","BK4568","IE00BJJMRY28.SGD","IE00BLSP4239.USD"],"gpt_icon":0},{"id":"2470722383","title":"赛诺菲32亿美元收购、与MNC长期合作，Translate Bio向肺部高效递送mRNA","url":"https://stock-news.laohu8.com/highlight/detail?id=2470722383","media":"动脉vcbeat","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470722383?lang=zh_cn&edition=full","pubTime":"2024-09-27 08:00","pubTimestamp":1727395200,"startTime":"0","endTime":"0","summary":"2021年8月3日，赛诺菲宣布与临床阶段mRNA治疗药物公司Translate Bio（纳斯达克股票代码：TBIO）达成了一项最终协议（definitive agreement），赛诺菲将以每股38美元收购Translate Bio的所有已发行股票，总计约32亿美元。这个价格较Translate Bio过去60天的每股成交量加权平均价格溢价56%。值得一提的是，尽管在早期管道中布...","market":"us","thumbnail":"https://inews.gtimg.com/om_ls/OusfQycWW6pAtmG4OsgXvXfJW1M4c4Cid5VSKUpleaIy8AA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/OusfQycWW6pAtmG4OsgXvXfJW1M4c4Cid5VSKUpleaIy8AA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20240927A014VI00","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20240927A014VI00","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent_tech","symbols":["BK4551","BNTX","BK4093","BK4548","CF","BK4568","BK4139","LPT","BK4588","BK4535","ARD","BK4585"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.biontech.de","stockEarnings":[{"period":"1week","weight":-0.0838},{"period":"1month","weight":-0.0846},{"period":"3month","weight":0.1709},{"period":"6month","weight":0.0535},{"period":"1year","weight":0.0513},{"period":"ytd","weight":-0.0322}],"compareEarnings":[{"period":"1week","weight":-0.0112},{"period":"1month","weight":0.0118},{"period":"3month","weight":0.0616},{"period":"6month","weight":0.1153},{"period":"1year","weight":0.3028},{"period":"ytd","weight":0.2423}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"BioNTech SE成立于2008年6月2日。该公司结合了数十年的免疫学，尖端治疗平台以及各种患者分析和生物信息学工具的开创性研究，开发针对癌症和其他疾病的个体化免疫疗法。该公司利用强大的新治疗机制，利用各种生物学靶点，利用每位患者免疫系统的力量，解决每位患者潜在疾病的独特分子特征。","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.036134},{"month":2,"riseRate":0.2,"avgChangeRate":-0.029347},{"month":3,"riseRate":0.8,"avgChangeRate":0.158218},{"month":4,"riseRate":0.2,"avgChangeRate":0.046183},{"month":5,"riseRate":0.8,"avgChangeRate":0.071246},{"month":6,"riseRate":0.6,"avgChangeRate":0.036711},{"month":7,"riseRate":1,"avgChangeRate":0.177192},{"month":8,"riseRate":0.6,"avgChangeRate":-0.048295},{"month":9,"riseRate":0.4,"avgChangeRate":0.02735},{"month":10,"riseRate":0.6,"avgChangeRate":0.01755},{"month":11,"riseRate":0.833333,"avgChangeRate":0.202366},{"month":12,"riseRate":0.4,"avgChangeRate":-0.023804}],"exchange":"NASDAQ","name":"BioNTech SE","nameEN":"BioNTech SE"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"BioNTech SE(BNTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供BioNTech SE(BNTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"BioNTech SE,BNTX,BioNTech SE股票,BioNTech SE股票老虎,BioNTech SE股票老虎国际,BioNTech SE行情,BioNTech SE股票行情,BioNTech SE股价,BioNTech SE股市,BioNTech SE股票价格,BioNTech SE股票交易,BioNTech SE股票购买,BioNTech SE股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"BioNTech SE(BNTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供BioNTech SE(BNTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}